🇺🇸 FDA
Patent

US 12390473

Methods of treating tyrosine kinase inhibitor-induced diarrhea

granted A61KA61K31/165A61K31/4164

Quick answer

US patent 12390473 (Methods of treating tyrosine kinase inhibitor-induced diarrhea) held by The Regents of the University of California expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/165, A61K31/4164, A61K31/4174, A61K31/426